Skip to main content

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 10, Number 6, September 2010

Articles

Antisense Treatment in Human Prostate Cancer and Melanoma
pp. 555-565(11)
Authors: Di Cresce, C.; Koropatnick, J.

Favourites:
ADD

Targeting Apoptotic Signaling Pathways in Human Lung Cancer
pp. 566-574(9)
Authors: Han, S.W.; Roman, J.

Favourites:
ADD

Too Much of a Good Thing: Suicide Prevention Promotes Chemoresistance in Ovarian Carcinoma
pp. 575-583(9)
Authors: Pennington, K.; Pulaski, H.; Pennington, M.; Liu, J.R.

Favourites:
ADD

Bid Stands at the Crossroad of Stress-Response Pathways
pp. 584-592(9)
Authors: Song, G.; Chen, G.G.; Hu, T.; Lai, P.B.S.

Favourites:
ADD
Favourites:
ADD

In Vitro and In Vivo Antitumor Efficacy of Docetaxel and Sorafenib Combination in Human Pancreatic Cancer Cells
pp. 600-610(11)
Authors: Ulivi, P.; Arienti, C.; Zoli, W.; Scarsella, M.; Carloni, S.; Fabbri, F.; Tesei, A.; Chiadini, E.; Orlandi, A.; Passeri, D.; Zupi, G.; Milandri, C.; Silvestrini, R.; Amadori, D.; Leonetti, C.

Favourites:
ADD

ZD6474, a Small Molecule Tyrosine Kinase Inhibitor, Potentiates the Anti-Tumor and Anti-Metastasis Effects of Radiation for Human Nasopharyngeal Carcinoma
pp. 611-622(12)
Authors: Yang, S.; Wu, J.; Zuo, Y.; Tan, L.; Jia, H.; Yan, H.; Zhu, X.; Zeng, M.; Ma, J.; Huang, W.

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more